Bidirectional Cohort Study of Nanfang Spondyloarthritis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Bidirectional Cohort Study of Nanfang Spondyloarthritis — Stella

Home/Spondyloarthritis (SpA)/

View on ClinicalTrials.gov

Recruiting

Back to Spondyloarthritis (SpA) trials

Trial locations(1 site)

China

Nanfang Hostipal,Southern Medical University, Guangzhou, Guangdong

Key details

Sponsor

Nanfang Hospital, Southern Medical University

Collaborators

Southern Medical University, China

Enrollment target

~3,000 participants

Started

May 2025

Primary completion

April 2030

Age range

10 Years – 59 Years

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.